Oncology Precision Medicine

March 6, 2021

The Advocate Aurora Health Oncology Precision Medicine Conference will review the use of molecular testing in molecular tumor boards at Advocate Aurora as well as other health systems. Speakers will discuss OPM from the standpoint of pathology, (tele) genetic counseling and implementation in clinical trials.

This conference is being held virtually.

Target Audience

This course is intended for Medical Oncologists, Cancer Surgeons, Pathologists, Genetic Counselors, All Medical Staff

Learning Objectives

At the end of this session, learners should be able to:

  1. Understand the multi-disciplinary nature of oncology precision medicine (OPM)
  2. Recognize the difficulties including pathology tissue, biomarker validation, and molecular ambiguity detection from testing results
  3. Appreciate the central importance of genetic counselors in the OPM process 
  4. Review examples of OPM clinical trials and real-world data generation to generate progress and value in oncology
Additional information
AttachmentSize
File Oncology Precision Medicine Flyer FINAL.pptx81.85 KB
Agenda: 

8:00am
Program Overview by Michael A. Thompson, MD, PhD, FASCO    

8:05am
Implementing OPM & Genetics at a Large Health System  
Kristen Hanson, MS, CGC   Genetic Counselor Sr, Genomic Medicine, Advocate Aurora Health
Mary Jo Luser, RN, OCN, CCRP  Research Coordinator, Aurora Cancer Care, Advocate Aurora Health
Michael P. Mullane, MD  Medical Director, Hereditary Cancer Prevention and Management Center, Advocate Aurora Health                        
Antony Ruggeri, MD  Medical Oncologist, Aurora Cancer Care, Advocate Aurora Health
Mary Walters, PharmD, BCOP

8:50am
Role of the Molecular Pathologist in OPM 
Alicia M Hunt, MD  Anatomic & Clinical Pathology,  Advocate Aurora Health

9:10am
Biomarker Validation
Dan Hayes, MD, FACP, FASCO  Clinical Director of the Breast Oncology Program, University of Michigan

9:30am
Navigating PD-1/PDL-1 Testing & Interpretation
Frank Zuehl MD  Anatomic & Clinical Pathology,  Advocate Aurora Health

9:50am
Implementing OPM in a Clinical Trial – HCRN BRE12-158
Milan Radovich, PhD  Co-Director of the IU Health Precision Genomics Program, IU Health Vice- President for Oncology Genomics

10:10am
NCI Molecular Analysis for Therapy Choice (MATCH) and v2.0, iMATCH, Combo MATCH  
Peter O’Dwyer, MD  Co-chair ECOG-ACRIN

10:30am - Exhibit Time

10:45am
ASCO-TAPUR: Testing the Use of Food & Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People with Advanced Stage Cancer
Edward S. Kim, MD , MBA  Physician-In-Chief, City of Hope OC; Immediate Past Chair, ASCO TAPUR Steering Committee

11:05am
Navigating Real World Data 
Thomas D. Brown, MD  Chief Medical Officer, Syapse

11:25am
Value in Oncology Precision Medicine
James Weese, MD, FACS    

11:45am
Q&A with Speakers

12:00pm
Wrap up by Michael A. Thompson, MD, PhD, FASCO

Course summary
Available credit: 
  • 3.75 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 3.75 Attendance
    Attendance Credit
    • 3.75 Approved AMA PRA Category 1 Credit™
Course opens: 
01/25/2021
Course expires: 
05/28/2021
Event starts: 
03/06/2021 - 8:00am CST
Event ends: 
03/06/2021 - 12:00pm CST
Cost:
$0.00
Add to calendar: 
Rating: 
3.5

Faculty

Michael A. Thompson, MD, PhD, FASCO  Medical Co-Director, Oncology Precision Medicine Program, Advocate Aurora Health 
Mary Walters, PharmD, BCOP  Co-Director, Oncology Precision Medicine Program, Advocate Aurora Health 
James Weese, MD, FACS  Vice President of Aurora Cancer Care, Advocate Aurora Health 
MJ Luser, Research Coordinator, Aurora Cancer Care, Advocate Aurora Health 
Michael P. Mullane, MD  Medical Director, Hereditary Cancer Prevention and Management Center, Advocate Aurora Health
Antony Ruggeri, MD  Medical Oncologist, Aurora Cancer Care, Advocate Aurora Health 
Kristen Hanson, Genetic Counselor Sr, Genomic Medicine, Hereditary Cancer Prevention and Management Center, Advocate Aurora Health 
Alicia M Hunt, MD  Anatomic & Clinical Pathology,  Advocate Aurora Health
Dan Hayes, MD, FACP, FASCO  Clinical Director of the Breast Oncology Program, University of Michigan
Frank Zuehl, MD  Anatomic & Clinical Pathology,  Advocate Aurora Health
Milan Radovich, PhD  Co-Director of the IU Health Precision Genomics Program, IU Health Vice- President for Oncology Genomics
Peter O’Dwyer, MD  Co-chair ECOG-ACRIN
Edward S. Kim, MD, MBA  Physician-In-Chief, City of Hope OC; Immediate Past Chair, ASCO TAPUR Steering Committee
Thomas D. Brown, MD  Chief Medical Officer, Syapse

 

Disclosure

Faculty disclosures are being reviewed and will be presented to the audience in advance of the program.

 

Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Advocate Aurora Health designates this live activity for a maximum of 3.75 AMA PRA Category 1 credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Part II
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


 

Available Credit

  • 3.75 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 3.75 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 3.75 Attendance
    Attendance Credit
    • 3.75 Approved AMA PRA Category 1 Credit™

VIRTUAL EXHIBIT HALL

Welcome to the Virtual Exhibit Hall. This is a space where companies share information about their products and services, showcase their latest innovations, and connect with attendees, faculty and course directors. Click out the "booths" below to learn about each exhibitor and get connected!

Exhibitors
Adaptive BiotechnologiesAstraZenecaBeiGene
Blueprint MedicinesBoehringer IngelheimBristol Myers Squibb 
Caris Life SciencesDaiichi-SankyoDeciphera Pharmaceuticals
EisaiExelixisGenentech Inc.
Genentech Inc. HematologyGlaxo (GSK)Guardant
Incyte CorporationIpsen BiopharmaceuticalsJanssen
Jazz PharmaceuticalsKaryopharm Therapeutics Inc.Merck
NovartisPfizer Institutional SalesPfizer Oncology
Regeneron Sanofi Genzyme AllianceRigel PharmaceuticalsSanofi Genzyme
Sanofi Genzyme Rare Blood Disorders  
   

 

Price

Cost:
$0.00
Please login or register to take this course.

 

This program will be recorded and posted online for ongoing viewing. Please turn your camera/video off if you do not want your image shared within the recorded video. If you have any concerns, please contact the CME Office at cme@aah.org.


Contact the Advocate Aurora Health CME Office at cme@aurora.org if you have any questions or need assistance.